已收盘 12-12 16:00:00 美东时间
+0.610
+1.98%
今日重点评级关注:Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从8美元升至8.25美元;Ascendiant Capital:维持Aytu BioPharma"买入"评级,目标价从12.5美元升至13美元
12-11 10:33
今日重点评级关注:Chardan Capital:维持Senti Biosciences"买入"评级,目标价从12美元升至13美元;Guggenheim:维持Praxis Precision Medicine"买入"评级,目标价从540美元升至760美元
12-10 10:33
G-III Apparel shares jumped after a profit beat, new dividend and higher earnings outlook offset weaker sales and margin pressure.
12-10 00:43
G-III Apparel Group ( ($GIII) ) has shared an update. On December 4, 2025, G-II...
12-09 20:59
G-III announced today that its Board of Directors has approved a new quarterly dividend program to evolve its strategic use of capital. The Board of Directors declared an initial quarterly cash dividend of $0.10 per
12-09 20:12
Fiscal 2026Net sales are expected to be approximately $2.98 billion (previous guidance $3.02 billion). This compares to net sales of $3.18 billion for fiscal 2025.Net income is expected to be between $121.0 million and
12-09 20:09
Companies Reporting Before The Bell • TH International (NASDAQ:THCH) is likely ...
12-09 19:11
今日重点评级关注:摩根士丹利:维持Kyverna Therapeutics"超配"评级,目标价从20美元升至25美元;Maxim Group:维持Capricor Therapeutics"买入"评级,目标价从25美元升至50美元
12-05 08:35
今日重点评级关注:Guggenheim:维持Cybin Inc. Common Shares"买入"评级,目标价从39美元升至48美元;HC Wainwright & Co.:维持Capricor Therapeutics"买入"评级,目标价从24美元升至60美元
12-04 09:38
G-III Apparel Group announced the release of its third quarter fiscal 2026 earnings on December 9, 2025, and will host a conference call at 8:30 a.m. ET that day. Investors can register in advance via a provided link for phone access or join a live webcast at [https://ir.g-iii.com](https://ir.g-iii.com). A replay will be available post-call. About G-III Apparel Group, Ltd, a global fashion leader, owns 10 iconic brands and licenses over 20 promin...
12-02 12:00